4/A: SI-BONE Director Corrects Stock Unit Reporting Error in Amended SEC Filing

Thomas A. West, a director at SI-BONE, Inc., filed an amended Form 4 to correct the number of shares issuable on the settlement of restricted stock units, clarifying that 18,315 shares are involved.

Summary

• Thomas A. West, a director of SI-BONE, Inc., filed an amended Form 4 with the SEC on June 27, 2024.
• This amendment corrects an error in the original Form 4 filed on the same date.
• The error pertained to the number of shares issuable upon the settlement of restricted stock units (RSUs).
• The corrected filing states that 18,315 shares are issuable upon settlement of the RSUs.
• Each RSU represents a contingent right to receive one share of SI-BONE's common stock.
• The shares will vest in 12 equal quarterly increments, starting on the Vesting Commencement Date, contingent upon the director's continuous service on the board.

Sentiment

Score: 7

Explanation: The document is a routine correction of a previous filing. It doesn't indicate any significant positive or negative developments for the company, but ensures accurate information is available to investors.

Future Outlook

The shares subject to the restricted stock unit will be vesting in a series of 12 equal quarterly increments starting on the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each applicable vesting date.

Industry Context

This filing is a routine disclosure related to insider transactions and equity compensation, common in the biotechnology industry where stock-based compensation is frequently used.

Key Dates